ATHENS, Greece–(BUSINESS WIRE)–  ANNOUNCEMENT FOR EUROPEAN MEDICAL & PHARMACEUTICAL TRADE MEDIA AND EUROPEAN FINANCIAL MEDIA ONLY GENESIS Pharma, a regional biopharma company focused on the commercialization of innovative medicines in Central and Eastern Europe, announces an exclusive agreement with Otsuka Pharmaceutical Europe Ltd. (OPEL), the European operation of global healthcare company Otsuka Pharmaceutical Co., Ltd., … [Read more…]

Reduces surface-bound viruses, bacteria and odors for safe, secure, and comfortable indoor environment TOKYO–(BUSINESS WIRE)–Mitsubishi Electric Corporation (TOKYO: 6503) announced today that in collaboration with Professor Toshiaki Kamachi and colleagues from the School of Life Science and Technology at Institute of Science Tokyo (Science Tokyo) they have achieved the world’s first mechanism for elucidating the … [Read more…]

Company to host webcast Monday, December 15, 2025 at 8:30 a.m. ET BOTHELL, Wash.–(BUSINESS WIRE)–Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced the company will host a conference call and webcast on Monday, December 15, 2025 at 8:30 am ET to disclose the topline results … [Read more…]

Precision biomarker company’s Scientific Advisory Board includes multiple Nobel Prize winners and the creators of current gold standard in Parkinson’s disease progression CAMBRIDGE, Mass., AUSTIN, Texas & TEL AVIV, Israel–(BUSINESS WIRE)–NeuraLight, the leader in developing precision biomarkers for neurological disease, today announced that Prof. Thomas Südhof, a Nobel Prize-winning neuroscientist and one of the world’s … [Read more…]

Strategic acquisition strengthens SBC’s comprehensive service offerings and R&D capabilities TOKYO–(BUSINESS WIRE)–#Healthcare–SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical” or the “Company”), a global provider of comprehensive consulting and management services for medical organizations, today announced the final results of its tender offer for common shares of Waqoo, Inc. (TOKYO:4937) (the “Tender Offer”), a … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Non-Opioid Therapeutics Market – Global Forecast 2025-2032” has been added to ResearchAndMarkets.com’s offering. This market research report focuses on the evolving landscape of the Non-Opioid Therapeutics Market. This sector has grown from USD 40.77 billion in 2024 to USD 43.78 billion in 2025, with projections suggesting a CAGR of 7.68% leading to a … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Alcohol Use Disorder Market – Global Forecast 2025-2032” report has been added to ResearchAndMarkets.com’s offering. The Alcohol Use Disorder Market is rapidly evolving as digital advancements, collaborative care models, and shifting regulatory dynamics converge to transform patient management and industry strategies. Comprehensive market analysis equips decision-makers with actionable insights into commercial opportunities, leading … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Hand Soap Market Report: Trends, Forecast and Competitive Analysis to 2031” has been added to ResearchAndMarkets.com’s offering. The global hand soap market is expected to grow with a CAGR of 6.7% from 2025 to 2031. Major drivers for this market include increasing awareness about hand hygiene globally, rising demand for natural organic hand … [Read more…]

Haleon earns distinction in the Family of Brands category for building enduring trust and consumer connection Award highlights Haleon’s leadership in purposeful innovation and consumer impact WARREN, N.J.–(BUSINESS WIRE)–Haleon, a global leader in consumer health, today announced it has been honored in Fast Company’s 2025 Brands That Matter list in the Family of Brands category, … [Read more…]

ANKTIVA plus BCG is the first immunotherapy for non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS), with or without papillary tumors, to receive a positive recommendation for marketing authorization in Europe. For patients whose disease does not respond to BCG, there are currently no authorized treatment options; the primary option is surgical removal … [Read more…]